Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, will host an analyst call to discuss the financial results for the period ended March 31, 2020. The webcast will begin at 6pm EDT Wednesday, May 27; 8am AEST Thursday, May 28, 2020.The live webcast can be accessed via:https://webcast.boardroom.media/mesoblast-limited/20200526/NaNmesoblast-q3-financial-results
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
-0.030(2.38%) |
Mkt cap ! $1.404B | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.30 | $1.22 | $10.22M | 8.142M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11752 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.23 | 67205 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.23 |
Change
-0.030 ( 3.67 %) |
||||
| Open | High | Low | Volume | ||
| $1.26 | $1.29 | $1.22 | 1670014 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| MSB (ASX) Chart |